Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 26 02:04PM ET
119.32
Dollar change
-1.19
Percentage change
-0.99
%
IndexS&P 500 P/E27.42 EPS (ttm)4.35 Insider Own0.39% Shs Outstand285.23M Perf Week-2.37%
Market Cap34.02B Forward P/E19.56 EPS next Y6.10 Insider Trans-2.27% Shs Float283.98M Perf Month-11.08%
Income1.26B PEG3.34 EPS next Q1.27 Inst Own89.95% Short Float1.38% Perf Quarter-11.30%
Sales6.53B P/S5.21 EPS this Y5.28% Inst Trans0.22% Short Ratio2.18 Perf Half Y-14.65%
Book/sh21.13 P/B5.65 EPS next Y9.53% ROA11.01% Short Interest3.91M Perf Year-19.08%
Cash/sh5.15 P/C23.19 EPS next 5Y8.21% ROE20.61% 52W Range117.17 - 155.35 Perf YTD-11.18%
Dividend Est.0.98 (0.82%) P/FCF25.93 EPS past 5Y5.63% ROI13.43% 52W High-23.20% Beta1.19
Dividend TTM0.96 (0.80%) Quick Ratio1.66 Sales past 5Y5.04% Gross Margin54.34% 52W Low1.83% ATR (14)3.34
Dividend Ex-DateApr 01, 2025 Current Ratio2.20 EPS Y/Y TTM3.67% Oper. Margin24.34% RSI (14)33.84 Volatility2.34% 2.90%
Employees17900 Debt/Eq0.56 Sales Y/Y TTM-3.00% Profit Margin19.27% Recom2.19 Target Price151.27
Option/ShortYes / Yes LT Debt/Eq0.56 EPS Q/Q-6.40% Payout21.31% Rel Volume0.59 Prev Close120.51
Sales Surprise-0.90% EPS Surprise2.26% Sales Q/Q1.39% EarningsFeb 26 AMC Avg Volume1.79M Price119.32
SMA20-2.84% SMA50-11.93% SMA200-12.43% Trades Volume762,387 Change-0.99%
Date Action Analyst Rating Change Price Target Change
Feb-10-25Upgrade Barclays Underweight → Equal Weight $135 → $145
Aug-28-24Initiated Wells Fargo Overweight $157
Jul-10-24Upgrade Citigroup Neutral → Buy $135 → $150
Jun-27-24Downgrade Wolfe Research Outperform → Peer Perform
Jun-03-24Resumed Jefferies Hold $135
Apr-05-24Upgrade Stifel Hold → Buy $145 → $163
Dec-13-23Initiated Wolfe Research Outperform $140
Dec-12-23Downgrade BofA Securities Buy → Neutral $130 → $133
Nov-17-23Downgrade UBS Buy → Neutral $163 → $125
Sep-28-23Initiated Bernstein Mkt Perform $123
Today 09:20AM
Mar-25-25 11:30AM
09:51AM
Mar-24-25 09:39AM
08:00AM
01:37PM Loading…
Mar-20-25 01:37PM
Mar-19-25 08:00AM
Mar-12-25 05:03AM
05:01AM
Mar-10-25 08:19AM
Mar-03-25 09:15AM
Feb-27-25 09:29PM
07:20PM
07:56AM
02:20AM
09:46PM Loading…
Feb-26-25 09:46PM
06:00PM
05:15PM
04:34PM
04:12PM
04:04PM
Feb-25-25 08:05AM
Feb-23-25 08:50AM
Feb-21-25 09:15AM
Feb-19-25 04:05PM
Jan-31-25 04:36PM
Jan-24-25 05:59PM
08:00AM
Jan-16-25 08:00AM
Jan-14-25 08:00PM
08:00AM Loading…
Jan-13-25 08:00AM
Jan-02-25 08:47AM
Dec-28-24 04:10PM
04:10PM
Dec-25-24 11:30AM
Dec-23-24 08:34AM
Dec-20-24 07:44PM
Dec-19-24 01:45PM
Dec-10-24 11:09AM
Dec-06-24 07:26PM
Dec-02-24 01:29PM
Nov-26-24 04:24PM
02:58PM
10:16AM
09:12AM
02:01AM
Nov-25-24 06:00PM
05:15PM
05:11PM
04:30PM
04:05PM
09:01AM
Nov-24-24 02:00PM
05:00AM
Nov-22-24 09:00AM
Nov-20-24 04:05PM
11:46AM
09:15AM
08:00AM
Nov-19-24 04:29PM
Nov-14-24 03:02PM
08:00AM
Nov-06-24 08:00AM
Oct-24-24 07:07PM
Oct-21-24 02:00AM
Oct-16-24 04:50PM
04:30PM
Oct-09-24 10:15AM
Oct-03-24 09:00PM
Sep-30-24 05:17PM
Sep-23-24 09:30AM
Sep-20-24 11:30AM
11:01AM
09:47AM
06:11AM
Sep-18-24 04:20PM
Sep-12-24 08:44AM
Sep-10-24 05:00PM
Sep-09-24 03:57PM
08:00AM
Sep-02-24 07:33AM
Aug-31-24 01:04AM
Aug-28-24 09:34AM
Aug-26-24 09:15AM
Aug-23-24 03:00PM
Aug-22-24 12:50PM
09:51AM
Aug-21-24 09:28PM
08:53PM
06:00PM
05:15PM
04:13PM
04:05PM
Aug-20-24 10:29AM
09:01AM
Aug-19-24 10:18AM
Aug-18-24 02:00PM
Aug-16-24 09:15AM
Aug-15-24 08:00AM
Aug-14-24 10:00AM
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gonsalves RodneyV.P., Corporate ControllerMar 17 '25Sale121.981,908232,69121,786Mar 18 02:17 PM
Gonsalves RodneyOfficerMar 17 '25Proposed Sale121.961,908232,692Mar 17 03:14 PM
Rataj Sue H.DirectorMar 06 '25Sale126.386,971881,00919,640Mar 07 04:11 PM
Rataj Sue H.DirectorMar 06 '25Proposed Sale126.386,971881,005Mar 06 02:27 PM
MCDONNELL PADRAIGPresident and CEOJan 21 '25Sale150.001,911286,65039,652Jan 23 07:20 PM
MCDONNELL PADRAIGOfficerJan 21 '25Proposed Sale150.001,911286,650Jan 21 10:53 AM
MCDONNELL PADRAIGPresident and CEOSep 27 '24Sale150.00477,05024,071Sep 30 01:08 PM
Grau DominiqueSenior Vice PresidentSep 26 '24Sale145.009,9901,448,55040,011Sep 27 05:02 PM
Grau DominiqueSenior Vice PresidentSep 26 '24Sale145.005,010726,45046,762Sep 27 05:02 PM
MCDONNELL PADRAIGOfficerSep 27 '24Proposed Sale150.00477,050Sep 27 12:19 PM
Grau DominiqueOfficerSep 26 '24Proposed Sale145.0015,0002,175,000Sep 26 02:52 PM
MCDONNELL PADRAIGPresident and CEOAug 22 '24Sale145.001,958283,91024,118Aug 23 11:43 AM
MCDONNELL PADRAIGOfficerAug 22 '24Proposed Sale145.001,958283,910Aug 22 12:39 PM
MCDONNELL PADRAIGPresident and CEOJul 26 '24Sale140.001,958274,12026,076Jul 30 10:42 AM
MCDONNELL PADRAIGOfficerJul 26 '24Proposed Sale140.001,958274,120Jul 26 10:56 AM
MCDONNELL PADRAIGPresident and CEOJun 18 '24Sale135.001,958264,33028,034Jun 20 06:54 PM
Grau DominiqueSenior Vice PresidentJun 10 '24Sale133.2815,0001,999,26249,486Jun 12 10:40 AM
MCDONNELL PADRAIGPresident and CEOJun 03 '24Sale130.001,958254,54025,185Jun 05 10:08 AM